Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.W.H | KHRNF | KHRWF

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Recent & Breaking News (TSXV:KHRN.H)

Khiron Life Sciences Announces Closing of the Sale of Its European Business

Newsfile November 17, 2023

Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business

Newsfile November 16, 2023

Khiron Life Sciences Agrees to $500,000 Secured Deposit

Newsfile June 5, 2023

IIROC Trading Halt - KHRN

Canada NewsWire May 8, 2023

KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER

Canada NewsWire May 6, 2023

Medical First: Germany Strengthens Reimbursement of Medical Cannabis

Newsfile April 25, 2023

Medical first: Germany strengthens medical cannabis reimbursement

Jonathon Brown April 25, 2023

Khiron Completes First Phase of Business Optimization

Newsfile April 20, 2023

KHIRON LIFE SCIENCES ANNOUNCES NEW CFO

Canada NewsWire April 17, 2023

Khiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment Option

Newsfile April 4, 2023

KHIRON LIFE SCIENCES ANNOUNCES SIZING OF MARKETED OFFERING OF UNITS

Canada NewsWire March 27, 2023

KHIRON LIFE SCIENCES ANNOUNCES PRICING OF MARKETED OFFERING OF UNITS

Canada NewsWire March 24, 2023

KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT MARKETED OFFERING

Canada NewsWire March 13, 2023

Khiron Closes Additional Loan with Investment-Grade Bank

Newsfile February 16, 2023

Khiron (TSXV:KHRN) closes revolving credit facility with financing company in Colombia

Azuka Onwuka February 14, 2023

Khiron Closes Revolving Credit Facility with Financing Company in Colombia

Newsfile February 14, 2023

Khiron begins dispensation of insurance-covered prescriptions in Colombia

PR Newswire January 19, 2023

NHS reimburses the cost of cannabis treatment to the first Zerenia(TM) Clinics UK patient

PR Newswire January 16, 2023

Khiron wins first medical cannabis contract with Colombia's largest public insurance company

PR Newswire January 9, 2023

Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products

PR Newswire January 5, 2023